VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for -Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1× · see citing works

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429 · see citing works

Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells.

Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,334 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

Zimprich, A. A., Benet‐Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 885 · see citing works

VPS35 Mutations in Parkinson Disease

Vilariño‐Güell, C., Wider, C. W., Ross, O. A., Dächsel, J. C., Kachergus, J. M., Lincoln, S., Soto‐Ortolaza, A. I., Cobb, S. A., Wilhoite, G. J., Bacon, J. A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.001 · Cited by 877 · see citing works

Chaperone-mediated autophagy: roles in disease and aging

Cuervo, A. M., & Wong, E. S. P. (2013) · Cell Research · doi:10.1038/cr.2013.153 · Cited by 850 · see citing works

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · see citing works

Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells

Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683 · see citing works

Diagnosis and treatment of Parkinson disease: molecules to medicine

Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 649 · see citing works

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

Martínez‐Vicente, M., Tallóczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J. R., Mosharov, E. V., Hodara, R., Fredenburg, R. A., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 633 · see citing works

Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer

Seaman, M. N. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312034 · Cited by 624 · see citing works

A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · see citing works

Interplay of LRRK2 with chaperone-mediated autophagy

Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588 · see citing works

Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

Alvarez‐Erviti, L., Rodríguez-Oroz, M. C., Cooper, J. A. D., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 550 · see citing works

RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk

MacLeod, D. A., Rhinn, H., Kuwahara, T., Zolin, A., Paolo, G. D., McCabe, B. D., Marder, K. S., Honig, L. S., Clark, L. N., Small, S. A., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.033 · Cited by 519 · see citing works

Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1

Kamp, F., Exner, N., Lutz, A., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K., et al. (2010) · EMBO Journal · doi:10.1038/emboj.2010.223 · Cited by 505 · see citing works

SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors

Temkin, P. A., Lauffer, B. E. L., Jäger, S., Cimermančič, P., Krogan, N. J., & von Zastrow, M. (2011) · Nature Cell Biology · doi:10.1038/ncb2252 · Cited by 460 · see citing works

Retromer

Bonifacino, J. S., & Hurley, J. H. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.03.009 · Cited by 449 · see citing works

Model‐guided microarray implicates the retromer complex in Alzheimer's disease

Small, S. A., Kent, K., Pierce, A., Leung, C., Kang, M. S., Okada, H., Honig, L., Vonsattel, J., & Kim, T. (2005) · Annals of Neurology · doi:10.1002/ana.20667 · Cited by 440 · see citing works

Evidence for a protein transported through the secretory pathway en route to the higher plant chloroplast

Villarejo, A., Burén, S., Larsson, S., Déjardin, A., Monné, M., Rudhe, C., Karlsson, J. E., Jansson, S., Lerouge, P., Rolland, N., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1330 · Cited by 369 · see citing works

Lysosomal Degradation of α-Synuclein in Vivo

Mak, S. K., McCormack, A. L., Manning-Bog, A., Cuervo, A. M., & Monte, D. A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074617 · Cited by 349 · see citing works

The Retromer Complex Influences Wnt Secretion by Recycling Wntless from Endosomes to the Trans-Golgi Network

Belenkaya, T. Y., Wu, Y., Tang, X., Zhou, B., Cheng, L., Sharma, Y. V., Yan, D., Selva, E. M., & Lin, X. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.12.003 · Cited by 323 · see citing works

Recycle your receptors with retromer

Seaman, M. N. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.12.004 · Cited by 309 · see citing works

Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

Xilouri, M., Brekk, O. R., & Stefanis, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8341-2 · Cited by 299 · see citing works

VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology

Wen, L., Tang, F., Hong, Y., Luo, S.-W., Wang, C.-L., He, W., Shen, C., Jung, J.-U., Xiong, F., Lee, D.-H., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105109 · Cited by 264 · see citing works

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

Qiao, L., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Yacoubian, T. A., Wilson, S. M., Xie, Z., Speake, L. D., Parks, R., Crabtree, D., et al. (2008) · Molecular Brain · doi:10.1186/1756-6606-1-17 · Cited by 261 · see citing works

Wnt Signaling Requires Retromer-Dependent Recycling of MIG-14/Wntless in Wnt-Producing Cells

Yang, P., Lorenowicz, M. J., Macůrková, M., Coudreuse, D. Y. M., Betist, M. C., & Korswagen, H. C. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.12.004 · Cited by 257 · see citing works

Retromer terminates the generation of cAMP by internalized PTH receptors

Feinstein, T. N., Wehbi, V. L., Ardura, J. A., Wheeler, D., Ferrandon, S., Gardella, T. J., & Vilardaga, J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.545 · Cited by 236 · see citing works

The Vps35 D620N Mutation Linked to Parkinson's Disease Disrupts the Cargo Sorting Function of Retromer

Follett, J., Norwood, S. J., Hamilton, N., Mohan, M., Kovtun, O., Tay, S. V., Yang, Z., Wood, S. A., Mellick, G. D., Silburn, P. A., et al. (2013) · Traffic · doi:10.1111/tra.12136 · Cited by 220 · see citing works

C. elegans AP-2 and Retromer Control Wnt Signaling by Regulating MIG-14/Wntless

Pan, C., Baum, P. D., Gu, M., Jørgensen, E. M., Clark, S. G., & Garriga, G. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.12.001 · Cited by 209 · see citing works

Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration

Xilouri, M., Brekk, O. R., Landeck, N., Pitychoutis, P. M., Papasilekas, T., Papadopoulou-Daifoti, Z., Kirik, D., & Stefanis, L. (2013) · Brain · doi:10.1093/brain/awt131 · Cited by 207 · see citing works

VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease

Miura, E., Hasegawa, T., Konno, M., Suzuki, M., Sugeno, N., Fujikake, N., Geisler, S., Tabuchi, M., Oshima, R., Kikuchi, A., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.014 · Cited by 195 · see citing works

Conditional Expression of Parkinson's Disease-Related Mutant -Synuclein in the Midbrain Dopaminergic Neurons Causes Progressive Neurodegeneration and Degradation of Transcription Factor Nuclear Receptor Related 1

Lin, X. Z., Parisiadou, L., Sgobio, C., Liu, G., Yu, J. H., Sun, L., Shim, H., Gu, X., Luo, J., Long, C., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1731-12.2012 · Cited by 188 · see citing works

Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein

Dhungel, N., Eleuteri, S., Li, L.-B., Kramer, N. J., Chartron, J. W., Spencer, B. J., Kosberg, K. A., Fields, J. A., Stafa, K., Adame, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.027 · Cited by 176 · see citing works

SNX–BAR proteins in phosphoinositide-mediated, tubular-based endosomal sorting

van Weering, J. R. T., Verkade, P., & Cullen, P. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.11.009 · Cited by 171 · see citing works

Update on the genetics of Parkinson's disease

Gasser, T. (2007) · Movement Disorders · doi:10.1002/mds.21676 · Cited by 167 · see citing works

Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Spiro, A. S., Furuta, A., Cooper, A. A., Garner, B., Kabuta, T., & Halliday, G. M. (2015) · Movement Disorders · doi:10.1002/mds.26141 · Cited by 163 · see citing works

Retromer-mediated direct sorting is required for proper endosomal recycling of the mammalian iron transporter DMT1

Tabuchi, M., Yanatori, I., Kawai, Y., & Kishi, F. (2010) · Journal of Cell Science · doi:10.1242/jcs.060574 · Cited by 143 · see citing works

Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N

Munsie, L. N., Milnerwood, A. J., Seibler, P., Beccano-Kelly, D. A., Tatarnikov, I., Khinda, J., Volta, M., Kadgien, C., Cao, L. P., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu582 · Cited by 143 · see citing works

Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated

Vieira, S. I., Rebelo, S., Esselmann, H., Wiltfang, J., Lah, J. J., Lane, R. F., Small, S. A., Gandy, S., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-40 · Cited by 141 · see citing works

Reversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1

Yin, D., Chen, Y., Lu, Y.-S., Bean, J. C., Sathyamurthy, A., Shen, C., Liu, X., Lin, T. W., Smith, C. A., Xiong, W., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.028 · Cited by 139 · see citing works

Animal Models of Parkinson's Disease: Vertebrate GeneticsPreprint

Lee, Y., Dawson, V. L., & Dawson, T. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009324 · Cited by 129 · see citing works

Retromer Is Required for Apoptotic Cell Clearance by Phagocytic Receptor Recycling

Chen, D., Xiao, H., Zhang, K., Wang, B., Gao, Z., Jian, Y., Qi, X., Sun, J., Miao, L., & Yang, C. (2010) · Science · doi:10.1126/science.1184840 · Cited by 123 · see citing works

Phosphatidylinositol transfer protein-α in netrin-1-induced PLC signalling and neurite outgrowth

Xie, Y., Ding, Y., Hong, Y., Zhu, F., Navarre, S., Xi, C.-X., Zhu, X., Wang, C.-L., Ackerman, S. L., Kozlowski, D. J., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1321 · Cited by 120 · see citing works

Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system

McFarland, N. R., Lee, J., Hyman, B. T., & McLean, P. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06010.x · Cited by 91 · see citing works

Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy

von Coelln, R., Thomas, B., Andrabi, S. A., Lim, K. L., Savitt, J. M., Saffary, R., Stirling, W. L. H., Bruno, K. J., Hess, E. J., Lee, M. K., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0414-06.2006 · Cited by 90 · see citing works

Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin

Lim, K., Ng, X., Grace, L. G.-Y., & Yao, T. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4105 · Cited by 79 · see citing works

VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1

Wang, C.-L., Tang, F., Peng, Y. W., Shen, C.-Y., Mei, L., & Xiong, W. (2012) · Biology Open · doi:10.1242/bio.20122451 · Cited by 75 · see citing works

Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration

Malkus, K. A., & Ischiropoulos, H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.017 · Cited by 71 · see citing works

AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications

Huang, X., Hartley, A.-V., Yin, Y., Herskowitz, J. H., Lah, J. J., & Ressler, K. J. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.06.008 · Cited by 68 · see citing works

Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling

Xia, W.-F., Tang, F.-L., Xiong, L., Xiong, S., Jung, J.-U., Lee, D., Li, X.-S., Feng, X., Mei, L., & Xiong, W.-C. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201207154 · Cited by 48 · see citing works

Live imaging of synaptic vesicle release and retrieval in dopaminergic neurons

Mani, M. (2009) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.003.2009 · Cited by 45 · see citing works

Vps35 haploinsufficiency results in degenerative-like deficit in mouse retinal ganglion neurons and impairment of optic nerve injury-induced gliosis

Liu, W., Tang, F., Erion, J., Xiao, H., Ye, J., & Xiong, W. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-10 · Cited by 23 · see citing works

Parkinson disease

Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415 · see citing works

The coming of age of chaperone-mediated autophagy

Kaushik, S., & Cuervo, A. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0001-6 · Cited by 1,422 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 598 · see citing works

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Michel, P. P., Hirsch, É. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 594 · see citing works

To degrade or not to degrade: Mechanisms and significance of endocytic recycling

Cullen, P. J., & Steinberg, F. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0053-7 · Cited by 590 · see citing works

The different autophagy degradation pathways and neurodegeneration

Fleming, A., Bourdenx, M., Fujimaki, M., Karabiyik, C., Krause, G. J., Lopez, A., Martín‐Segura, A., Puri, C., Scrivo, A., Skidmore, J., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.017 · Cited by 485 · see citing works

Defects in trafficking bridge Parkinson’s disease pathology and genetics

Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462 · see citing works

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

Mazzulli, J. R., Zunke, F., Ole Isacson, A., Studer, L., & Krainc, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520335113 · Cited by 382 · see citing works

Autophagy in Parkinson's Disease

Hou, X., Watzlawik, J. O., Fiesel, F. C., & Springer, W. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.037 · Cited by 355 · see citing works

Selective autophagy as a potential therapeutic target for neurodegenerative disorders

Scrivo, A., Bourdenx, M., Pampliega, O., & Cuervo, A. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30238-2 · Cited by 355 · see citing works

VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function

Tang, F., Liu, W., Hu, J.-X., Erion, J., Ye, J., Mei, L., & Xiong, W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.001 · Cited by 274 · see citing works

Autophagy and A lpha‐ S ynuclein: R elevance to P arkinson's D isease and R elated S ynucleopathies

Xilouri, M., Brekk, O. R., & Stefanis, L. (2016) · Movement Disorders · doi:10.1002/mds.26477 · Cited by 266 · see citing works

Autophagy, aging, and age-related neurodegeneration

Palmer, J. E., Wilson, N., Son, S. M., Obrocki, P., Wróbel, L., Rob, M., Takla, M., Korolchuk, V. I., & Rubinsztein, D. C. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.015 · Cited by 255 · see citing works

Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases

Djajadikerta, A., Keshri, S., Tanasa, M. P., Prestil, R., Ryan, L., & Rubinsztein, D. C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.035 · Cited by 238 · see citing works

Impaired dopamine release in Parkinson’s disease

Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J., & Wade-Martins, R. (2023) · Brain · doi:10.1093/brain/awad064 · Cited by 207 · see citing works

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease

Zeng, X., Geng, W.-S., Jia, J., Chen, L., & Zhang, P.-P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00109 · Cited by 194 · see citing works

Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles

Bernal-Conde, L. D., Ramos-Acevedo, R., Reyes-Hernández, M. A., Balbuena-Olvera, A. J., Morales-Moreno, I. D., Argüero‐Sánchez, R., Schüle, B., & Guerra‐Crespo, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01399 · Cited by 188 · see citing works

GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers

Kim, S., Yun, S. P., Lee, S., Umanah, G. K. E., Bandaru, V. V. R., Yin, X., Rhee, P., Karuppagounder, S. S., Kwon, S., Lee, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700465115 · Cited by 179 · see citing works

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?

Devoto, V. M. P., & Falzone, T. L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.026294 · Cited by 180 · see citing works

VPS35, the Retromer Complex and Parkinson’s Disease

Williams, E. T., Chen, X., & Moore, D. J. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-161020 · Cited by 173 · see citing works

Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies

Karpowicz, R. J., Haney, C. M., Mihaila, T. S., Frasier, R. M., Petersson, E. J., & Lee, V. M. ‐. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780296 · Cited by 165 · see citing works

The cell biology of Parkinson’s disease

Panicker, N., Ge, P., Dawson, V. L., & Dawson, T. M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012095 · Cited by 164 · see citing works

Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy

Kuo, S.-H., Tasset, I., Cheng, M. M., Diaz, A., Pan, M.-K., Lieberman, O. J., Hutten, S. J., Alcalay, R. N., Kim, S., Ximénez-Embún, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm6393 · Cited by 153 · see citing works

Endocytic membrane trafficking and neurodegenerative disease

Schreij, A. M. A., Fon, E. A., & McPherson, P. S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2105-x · Cited by 153 · see citing works

Dysfunction of Cellular Proteostasis in Parkinson’s Disease

Lehtonen, Š., Sonninen, T.-M., Wojciechowski, S., Goldsteins, G., & Koıstınaho, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00457 · Cited by 145 · see citing works

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

Quadri, M., Mandemakers, W., Grochowska, M. M., Masius, R., Geut, H., Fabrizio, E., Breedveld, G. J., Kuipers, D., Minneboo, M., Vergouw, L. J. M., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30179-0 · Cited by 143 · see citing works

Autophagy impairment in Parkinson’s disease

Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 137 · see citing works

DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy

Xu, C., Kang, W., Chen, Y., Jiang, T., Zhang, J., Zhang, L., Ding, J., Liu, J., & Chen, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00308 · Cited by 138 · see citing works

Role of the endolysosomal system in Parkinson’s disease

Vidyadhara, D. J., Lee, J. E., & Chandra, S. S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14820 · Cited by 131 · see citing works

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

Senkevich, K. A., & Gan‐Or, Z. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.015 · Cited by 135 · see citing works

The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses

Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 126 · see citing works

ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway

Mercado, G., Castillo, V., Soto, P., & Sidhu, A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.042 · Cited by 119 · see citing works

Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration

Chen, X., Kordich, J. K., Williams, E. T., Levine, N. D., Cole-Strauss, A., Marshall, L. L., Labrie, V., Ma, J., Lipton, J. W., & Moore, D. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814909116 · Cited by 114 · see citing works

The Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction

Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2019) · Movement Disorders · doi:10.1002/mds.27895 · Cited by 114 · see citing works

Chaperone‐mediated autophagy: Molecular mechanisms, biological functions, and diseases

Yao, R., & Shen, J. (2023) · MedComm · doi:10.1002/mco2.347 · Cited by 111 · see citing works

Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis

Ren, Z., Wang, C., Wang, T., Ding, H., Zhou, M., Yang, N., Liu, Y., & Chan, P. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0077-8 · Cited by 109 · see citing works

Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review

Wang, Z., Liu, J., Zhu, Z., Su, C.-F., Sreenivasmurthy, S. G., Iyaswamy, A., Lu, J., Chen, G., Song, J., & Li, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110968 · Cited by 108 · see citing works

The Multiple Roles of Autophagy in Neural Function and Diseases

Li, Y., Qin, Z., & Sheng, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01120-y · Cited by 106 · see citing works

Endosomal sorting and trafficking, the retromer complex and neurodegeneration

Vagnozzi, A. N., & Praticò, D. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0221-3 · Cited by 95 · see citing works

Key genes and convergent pathogenic mechanisms in Parkinson disease

Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 102 · see citing works

Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications

Balestrino, R., & Schapira, A. H. V. (2018) · The Neuroscientist · doi:10.1177/1073858417748875 · Cited by 96 · see citing works

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders

Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D. L., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 95 · see citing works

The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases

Zhang, H., Huang, T. Y., Hong, Y., Yang, W., Zhang, X., Luo, H., Xu, H., & Wang, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00079 · Cited by 89 · see citing works

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?

O’Hara, D. M., Pawar, G. N., Kalia, S. K., & Kalia, L. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00577 · Cited by 84 · see citing works

ɑ‐Synuclein strains and the variable pathologies of synucleinopathies

Peelaerts, W., & Baekelandt, V. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13595 · Cited by 89 · see citing works

α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters

Chistiakov, D. A., & Chistiakov, A. A. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0679-1 · Cited by 86 · see citing works

Quantitative proteomic analysis of Parkin substrates in Drosophila neurons

Martinez, A., Lectez, B. L. P., Ramírez, J., Popp, O., Sutherland, J. D., Urbé, S., Dittmar, G., Clague, M. J., & Mayor, U. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0170-3 · Cited by 83 · see citing works

Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice

Appel, J. R., Ye, S., Tang, F., Sun, D., Zhang, H., Mei, L., & Xiong, W. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3621-17.2018 · Cited by 82 · see citing works

VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation

Tian, Y., Tang, F., Sun, X.-D., Wen, L., Mei, L., Tang, B.-S., & Xiong, W. (2015) · Molecular Brain · doi:10.1186/s13041-015-0156-4 · Cited by 82 · see citing works

α-synuclein impairs autophagosome maturation through abnormal actin stabilization

Sarkar, S., Olsen, A. L., Sygnecka, K., Lohr, K. M., & Feany, M. Β. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009359 · Cited by 79 · see citing works

Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration

Peng, W., Minakaki, G., Nguyen, M., & Krainc, D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00742-3 · Cited by 79 · see citing works

Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease

Pitcairn, C., Wani, W. Y., & Mazzulli, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.008 · Cited by 75 · see citing works

Autophagy in Astrocytes and its Implications in Neurodegeneration

Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 74 · see citing works

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease

Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 76 · see citing works

Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice

Ishizu, N., Yui, D., Hebisawa, A., Aizawa, H., Cui, W., Fujita, Y., Hashimoto, K., Ajioka, I., Mizusawa, H., Yokota, T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw279 · Cited by 68 · see citing works

The Role of VPS35 in the Pathobiology of Parkinson’s Disease

Sassone, J., Reale, C., Dati, G., Regoni, M., Pellecchia, M. T., & Garavaglia, B. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00849-8 · Cited by 67 · see citing works

Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis

Muzio, L., Sirtori, R., Gornati, D., Eleuteri, S., Fossaghi, A., Brancaccio, D., Manzoni, L., Ottoboni, L., Feo, L. D., Quattrini, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17524-7 · Cited by 64 · see citing works

Emerging concepts of mitochondrial dysfunction in Parkinson’s disease progression: Pathogenic and therapeutic implications

Rani, L., & Mondal, A. C. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.09.010 · Cited by 68 · see citing works

The Emerging Roles of Autophagy in Human Diseases

Lei, Y., & Klionsky, D. J. (2021) · Biomedicines · doi:10.3390/biomedicines9111651 · Cited by 66 · see citing works

Chaperone mediated autophagy in aging: Starve to prosper

Xilouri, M., & Stefanis, L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.001 · Cited by 62 · see citing works

Are rodent models of Parkinson’s disease behaving as they should?

Vingill, S., Connor‐Robson, N., & Wade‐Martins, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.021 · Cited by 60 · see citing works

Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque

Koprich, J. B., Johnston, T. H., Reyes, G., Omana, V. N., & Brotchie, J. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167235 · Cited by 61 · see citing works

Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities

Wang, Y.-T., & Lu, J. (2022) · Cells · doi:10.3390/cells11142250 · Cited by 60 · see citing works

The LRRK2–macroautophagy axis and its relevance to Parkinson's disease

Manzoni, C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160265 · Cited by 57 · see citing works

The emerging role of retromer in neuroprotection

McMillan, K. J., Korswagen, H. C., & Cullen, P. J. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.004 · Cited by 60 · see citing works

Deregulation of autophagy and vesicle trafficking in Parkinson’s disease

Sheehan, P., & Yue, Z. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.013 · Cited by 56 · see citing works

Mitochondrial and Clearance Impairment in p. D620N VPS35 Patient‐Derived Neurons

Hanss, Z., Larsen, S. B., Antony, P. M. A., Mencke, P., Massart, F., Jarazo, J., Schwamborn, J. C., Barbuti, P. A., Mellick, G. D., & Krüger, R. (2020) · Movement Disorders · doi:10.1002/mds.28365 · Cited by 57 · see citing works

The autophagic degradation of Cav-1 contributes to PA-induced apoptosis and inflammation of astrocytes

Chen, Z., Nie, S., Qu, M., Zhou, D., Wu, L., Shi, X., Ma, L.-R., Li, X., Zhou, S., Wang, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0795-3 · Cited by 55 · see citing works

Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease

Peña‐Díaz, S., García‐Pardo, J., & Ventura, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030839 · Cited by 53 · see citing works

VPS35 regulates cell surface recycling and signaling of dopamine receptor D1

Wang, C., Niu, M., Zhou, Z., Zheng, X., Zhang, L., Tian, Y., Yu, X., Bu, G., Xu, H., Ma, Q., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.016 · Cited by 52 · see citing works

The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking

Kim, M. J., Deng, H., Wong, Y. C., Siddique, T., & Krainc, D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw413 · Cited by 52 · see citing works

Contributions of VPS35 Mutations to Parkinson’s Disease

Rahman, A. A., & Morrison, B. E. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.006 · Cited by 50 · see citing works

Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies

Dai, L., Liu, M., Ke, W., Chen, L., Fang, X., & Zhang, Z. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05419-5 · Cited by 51 · see citing works

Interdependency Between Autophagy and Synaptic Vesicle Trafficking: Implications for Dopamine Release

Limanaqi, F., Biagioni, F., Gambardella, S., Ryskalin, L., & Fornai, F. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00299 · Cited by 49 · see citing works

Retromer subunit, VPS29, regulates synaptic transmission and is required for endolysosomal function in the aging brain

Ye, H., Ojelade, S. A., Li‐Kroeger, D., Zuo, Z., Wang, L., Li, Y., Gu, J. Y. J., Tepaß, U., Rodal, A. A., Bellen, H. J., et al. (2020) · eLife · doi:10.7554/elife.51977 · Cited by 52 · see citing works

(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model

Chiu, C., Weng, Y.-H., Huang, Y., Chen, R., Liu, Y., Yeh, T., Lu, C., Lin, Y., Chen, Y.-J., Hsu, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03228-9 · Cited by 51 · see citing works

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease

Williams, E. T., Chen, X., Otero, P. A., & Moore, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105768 · Cited by 49 · see citing works

Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer

Hubert, V., Weiss, S., Rees, A. J., & Kain, R. (2022) · Cells · doi:10.3390/cells11162562 · Cited by 50 · see citing works

Parkinson's disease-associated pathogenic VPS35 mutation causes complex I deficits

Zhou, L., Wang, W., Hoppel, C. L., Liu, J., & Zhu, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.032 · Cited by 49 · see citing works

Chaperone-mediated autophagy controls the turnover of E3 ubiquitin ligase MARCHF5 and regulates mitochondrial dynamics

Nie, T., Tao, K., Zhu, L., Huang, L. H., Hu, S., Yang, R., Xu, P., Mao, Z., & Yang, Q. (2020) · Autophagy · doi:10.1080/15548627.2020.1848128 · Cited by 49 · see citing works

Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons

Tang, F., Zhao, L., Zhao, Y., Sun, D., Zhu, X., Mei, L., & Xiong, W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-019-0487-2 · Cited by 47 · see citing works

Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans

Courtland, J. L., Bradshaw, T. W., Waitt, G. M., Soderblom, E. J., Ho, T., Rajab, A., Vancini, R. G., Kim, H., & Soderling, S. H. (2021) · eLife · doi:10.7554/elife.61590 · Cited by 46 · see citing works

Advances in animal models of Parkinson's disease

He, S., Ru, Q., Chen, L., Xu, G., & Wu, Y. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111024 · Cited by 46 · see citing works

VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease

Niu, M., Zhao, F., Bondelid, K. S., Siedlak, S. L., Torres, S. L., Fujioka, H., Wang, W., Liu, J., & Zhu, X. (2021) · Aging Cell · doi:10.1111/acel.13347 · Cited by 46 · see citing works

Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology

Ren, X., Yao, L., Wang, Y., Mei, L., & Xiong, W. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02422-0 · Cited by 44 · see citing works

AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype

Boon, N., Lu, X., Andriessen, C. A., Moustakas, I., Buck, T. M., Freund, C., Arendzen, C. H., Böhringer, S., Boon, C. J. F., Mei, H., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.03.014 · Cited by 46 · see citing works

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?

Hu, D., Liu, Z., & Qi, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.746873 · Cited by 44 · see citing works

A conserved retromer sorting motif is essential for mitochondrial DLP1 recycling by VPS35 in Parkinson’s disease model

Wang, W., Ma, X., Zhou, L., Liu, J., & Zhu, X. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw430 · Cited by 44 · see citing works

Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma

Auzmendi-Iriarte, J., & Matheu, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.630743 · Cited by 45 · see citing works

Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association

Teixeira, M., Sheta, R., Idi, W., & Oueslati, A. (2021) · Biomolecules · doi:10.3390/biom11091333 · Cited by 43 · see citing works

Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health

Daly, J. L., Danson, C. M., Lewis, P. A., Zhao, L., Riccardo, S., Filippo, L. D., Cacchiarelli, D., Lee, D., Cross, S., Heesom, K. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38719-8 · Cited by 41 · see citing works

Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges

Kett, L. R., & Dauer, W. T. (2016) · Movement Disorders · doi:10.1002/mds.26797 · Cited by 42 · see citing works

VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology

Cutillo, G., Simon, D. K., & Eleuteri, S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105056 · Cited by 42 · see citing works

Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders

Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 41 · see citing works

Modulating autophagy and mitophagy as a promising therapeutic approach in neurodegenerative disorders

Mishra, J., Bhatti, G. K., Sehrawat, A., Singh, C., Singh, A., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121153 · Cited by 37 · see citing works

Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?

Morgan, A., Rees, D., Andrews, Z., & Davies, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.027 · Cited by 39 · see citing works

Biallelic VPS35L pathogenic variants cause 3C/Ritscher-Schinzel-like syndrome through dysfunction of retriever complex

Kato, K., Oka, Y., Muramatsu, H., Vasilyev, F. F., Otomo, T., Oishi, H., Kawano, Y., Kidokoro, H., Nakazawa, Y., Ogi, T., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106213 · Cited by 39 · see citing works

Chaperone-mediated autophagy as a therapeutic target for Parkinson disease

Campbell, P., Morris, H. R., & Schapira, A. H. V. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1517156 · Cited by 38 · see citing works

The Golgi Apparatus: A Voyage through Time, Structure, Function and Implication in Neurodegenerative Disorders

Mohan, A. G., Calenic, B., Ghiurau, N. A., Duncea-Borca, R., Constantinescu, A.-E., & Constantinescu, I. (2023) · Cells · doi:10.3390/cells12151972 · Cited by 36 · see citing works

Chaperone-mediated autophagy: Advances from bench to bedside

Li, W., Nie, T., Xu, H., Yang, J. H., Yang, Q., & Mao, Z. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.010 · Cited by 36 · see citing works

VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease

Chen, X., Tsika, E., Levine, N. D., & Moore, D. J. (2023) · Figshare · doi:10.6084/m9.figshare.c.6776689

VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function

Tang, F., Liu, W., Hu, J.-X., Erion, J., Ye, J., Mei, L., & Xiong, W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.001 · Cited by 274 · see citing works

VPS35 and retromer dysfunction in Parkinson's disease

Rowlands, J., & Moore, D. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0384 · Cited by 22 · see citing works

VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease

Miura, E., Hasegawa, T., Konno, M., Suzuki, M., Sugeno, N., Fujikake, N., Geisler, S., Tabuchi, M., Oshima, R., Kikuchi, A., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.014 · Cited by 195 · see citing works

Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration

Fu, C., Yang, N., Chuang, J.-Z., Nakajima, N., Iraha, S., Roy, N. S., Wu, Z., Jiang, Z., Otsu, W., Radu, R. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50189-0 · Cited by 9 · see citing works